Rationale and Design for an Investigation to Optimize Selective Serotonin Reuptake Inhibitor Treatment for Pregnant Women with Depression

被引:13
作者
Avram, M. J. [1 ]
Stika, C. S. [2 ]
Rasmussen-Torvik, L. J. [3 ]
Ciolino, J. D. [3 ]
Pinheiro, E. [4 ]
George, A. L., Jr. [5 ]
Wisner, K. L. [4 ]
机构
[1] Northwestern Univ, Feinberg Sch Med, Dept Anesthesiol, Chicago, IL 60611 USA
[2] Northwestern Univ, Dept Obstet & Gynecol, Feinberg Sch Med, Chicago, IL 60611 USA
[3] Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA
[4] Northwestern Univ, Dept Psychiat & Behav Sci, Feinberg Sch Med, Chicago, IL 60611 USA
[5] Northwestern Univ, Dept Pharmacol, Feinberg Sch Med, Chicago, IL 60611 USA
关键词
D O I
10.1002/cpt.375
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The physiological changes of pregnancy can affect the pharmacokinetics of a drug, thereby affecting its dose requirements. Because pharmacokinetic (PK) studies in pregnant women have rarely been conducted, evidence-based dosing adjustments are seldom available. In particular, despite the fact that the use of antidepressants has become increasingly common, pregnancy-associated PK changes of the selective serotonin reuptake inhibitors (SSRIs) are largely unknown.
引用
收藏
页码:31 / 33
页数:3
相关论文
共 5 条
[1]   Pregnancy-induced changes in pharmacokinetics - A mechanistic-based approach [J].
Anderson, GD .
CLINICAL PHARMACOKINETICS, 2005, 44 (10) :989-1008
[2]  
Anger GJ, 2011, REPRODUCTIVE AND DEVELOPMENTAL TOXICOLOGY, P39, DOI 10.1016/B978-0-12-382032-7.10004-9
[3]   Obstetric pharmacokinetic dosing studies are urgently needed [J].
McCormack, Shelley A. ;
Best, Brookie M. .
FRONTIERS IN PEDIATRICS, 2014, 2
[4]   Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008 [J].
Mitchell, Allen A. ;
Gilboa, Suzanne M. ;
Werler, Martha M. ;
Kelley, Katherine E. ;
Louik, Carol ;
Hernandez-Diaz, Sonia .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2011, 205 (01) :51.e1-51.e8
[5]  
Stika C., 2012, PRINCIPLES CLIN PHAR, P395